搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FiercePharma
1 小时
Fujifilm Diosynth CEO heralds 2025 as 'biggest year' yet for CDMO's $8B+ expansion drive
By August or September of this year, Petersen said he expects “basically half” of the company’s $8 billion in manufacturing ...
FiercePharma
1 小时
After slow rollout, Merck's Winrevair poised for 'strong uptake' in 2025: Leerink
Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...
FiercePharma
4 小时
As Super Bowl nears, TV data show GLP-1 game day ads enjoyed a big year
Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...
FiercePharma
3 小时
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...
FiercePharma
3 小时
Seeking new social media horizons, EMA joins mass migration from X to Bluesky
As users continue to leave X (formerly Twitter) en masse, many in favor of the newer Bluesky platform, the European Medicines ...
FiercePharma
4 小时
Recapping the 2025 J.P. Morgan Healthcare Conference
This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...
FiercePharma
5 小时
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...
FiercePharma
23 小时
RFK Jr.'s referral fees in litigation over Merck's Gardasil raise conflict-of-interest ...
Department of Health and Human Services (HHS) secretary nominee Robert F. Kennedy Jr. plans to continue to receive referral fees from a law firm that is suing pharma powerhouse Merck & Co. | ...
FiercePharma
1 天
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
FiercePharma
1 天
JPM25: Incyte plans to turn 'a lot of cards' in 2025 as CEO eyes 2 types of deals
During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...
FiercePharma
2 天
J&J stands by sales growth ambitions—and points to potential Tremfya boon—as Stelara ...
As Stelara biosimilars chip away at sales in Europe and off-brand rivals start to grace the stage in the U.S., Johnson & ...
FiercePharma
1 天
AbbVie logs 3rd straight year as top TV drug ad spender
Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈